Literature DB >> 9834739

Treatment of hyperfunctional lines of the face with botulinum toxin A.

W J Binder1, A Blitzer, M F Brin.   

Abstract

Since Botulinum toxin A became a mainstay therapy for blepharospasm, its use in treating other dystonic conditions, spasticity disorders, as well as hyperfunctional lines of the face has increased exponentially in recent years. The following article summarizes our experience in establishing a safe and reliable method of administration of botulinum toxin A for treating hyperfunctional lines of the face.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9834739     DOI： 10.1111/j.1524-4725.1998.tb04098.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN： 1076-0512            Impact factor:   3.398


  16 in total

1.  Management of gummy smile with Botulinum Toxin Type-A: A case report.

Authors:  Sudeeptha Dinker; A Anitha; Abhinay Sorake; Kishore Kumar
Journal:  J Int Oral Health       Date:  2014-02-26

2.  Botox as an adjunct to orthognathic surgery for a case of severe vertical maxillary excess.

Authors:  Adarsh S Indra; P P Biswas; V T Vineet; T Yeshaswini
Journal:  J Maxillofac Oral Surg       Date:  2011-02-25

3.  Anatomocosmetic implication rules of the corrugator supercilii muscle for youthful eye appearance.

Authors:  Yelda Pinar; Figen Govsa; Mehmet Asim Ozer; Ilgen Ertam
Journal:  Surg Radiol Anat       Date:  2016-03-28       Impact factor: 1.246

Review 4.  A review of the longevity of effect of botulinum toxin in wrinkle treatments.

Authors:  G Wright; A Lax; S B Mehta
Journal:  Br Dent J       Date:  2018-02-23       Impact factor: 1.626

Review 5.  Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.

Authors:  Till Sprenger; M Viana; C Tassorelli
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 6.  Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine.

Authors:  P Barbanti; G Egeo; L Fofi; C Aurilia; S Piroso
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

7.  Botulinum toxin type a for the treatment of hyperkinetic lines of the face.

Authors:  Dinesh Singh Chauhan; K M Cariappa; Yadavalli Guruprasad
Journal:  J Maxillofac Oral Surg       Date:  2012-08-28

Review 8.  Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Authors:  Roshni Ramachandran; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

9.  The efficacy of botulinum toxin type-A for intractable chronic migraine patients with no pain-free time.

Authors:  Dominic Atraszkiewicz; Rieko Ito; Anish Bahra
Journal:  Br J Pain       Date:  2021-05-24

10.  Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine.

Authors:  Carrie E Robertson; Ivan Garza
Journal:  Neuropsychiatr Dis Treat       Date:  2012-01-13       Impact factor: 2.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.